Treatment of Candida albicans with sublethal concentration of keanumycin A

ABSTRACT: To determine the potential mode of action of the new antifungal compound candidate keanumycin A, the C. albicans wild type SC5314 was exposed to a sublethal dose of the substance. Untreated samples serve as control.

INSTRUMENT(S): GenePix 4000B

ORGANISM(S): Candida albicans

SUBMITTER: Sascha Brunke 

PROVIDER: E-MTAB-12311 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress